RightCare Signs Hunterdon Medical Center as First NJ Provider, Helps with CARE Act Compliance Hunterdon Medical Center will use RightCare to improve patient care and promote overall wellness in the local Flemington community
October 22, 2015Using an evidence-based algorithm fed by patient-specific psychosocial information to determine risk for readmission and associated need for post-acute care, RightCare can then match, refer, and transition patients to services that best meet their needs.
More »
NeuroPace RNS® System Associated with Positive Effects In Memory and Language for People Living with Partial Onset Epilepsy
October 22, 2015The results from this study are clinically meaningful because it is common for people living with epilepsy to have significant challenges in memory function, mental processing and reasoning, verbal communication, and decision making.
More »
Celator(R) Pharmaceuticals Announces VYXEOS(TM) (CPX-351) Shows No QT/QTc Interval Prolongation in an Intensive QT/QTc Study
October 21, 2015This Phase 2 PK/PD study in adult patients with acute hematologic malignancies was conducted to support FDA requirements of a NDA, which Celator hopes to file for VYXEOS after completing a Phase 3 study in patients with high risk acute myeloid leukemia.
More »